Living with Von Willebrand Disease
Links shared publicly online about this topic
von Willebrand Disease
kidshealth.org — “Excessive or prolonged bleeding could be a sign of von Willebrand disease. Learn more about this genetic disorder that affects the blood's ability to clot.” View full resource at kidshealth.org
Most Recently Shared on August 5, 2009 at 5:12 pm By:
von Willebrand Disease http://kidshealth.org/parent/medical/heart/vwd.html
Oncology Article - von Willebrand Factor
mdlinx.com — “Variation in the von Willebrand Factor gene is associated with VWF levels and with the risk of cardiovascular disease” View full resource at mdlinx.com
Most Recently Shared on October 28, 2010 at 3:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Variation in the von Willebrand Factor gene is associated with VWF levels and with the risk of cardiovasc... http://bit.ly/cG3bcJ #oncology
Von Willebrand's Disease and Thrombotic Thrombocyopenic Purpura | VEOMED
veomed.com — “Von Willebrand's Disease and Thrombotic Thrombocyopenic Purpura | VEOMED” View full resource at veomed.com
Most Recently Shared on August 22, 2010 at 11:05 pm By:
Von Willebrand’s Disease and Thrombotic Thrombocyopenic Purpura, J. Sadler,Dept. Medicine, Washington University Medicine http://ow.ly/2t7MN
Pediatrics Medical News about von Willebrand Disease Adolescent Menorrhagia
mdlinx.com — “Cost-Utility Analysis of von Willebrand Disease Screening in Adolescents with Menorrhagia” View full resource at mdlinx.com
Most Recently Shared on May 15, 2010 at 6:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cost-Utility Analysis of von Willebrand Disease Screening in Adolescents with Menorrhagia: The Journal of Ped... http://bit.ly/bpctus #peds
Wilate available for bleeding episodes in von Willebrand disease (VWD) - ONA
oncologynurseadvisor.com — “Octapharma announced that wilate (double virus inactivated von Willebrand Factor/Coagulation Factor VIII concentrate [human]) is now available by prescription for the treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as in patients with mild or moderate forms of the illness in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 13, 2010 at 5:02 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Wilate available for bleeding episodes in von Willebrand disease (VWD) http://goo.gl/fb/ef0rn
02 Von Willebrand's Disease - VeterinaryPartner.com - a VIN company!
veterinarypartner.com — “02 Von Willebrand's Disease - VeterinaryPartner.com - a VIN company!” View full resource at veterinarypartner.com
Most Recently Shared on November 28, 2010 at 10:13 am By:
Newport Beach Vet Veterinarian
Doberman, Xaira, suffered a bleeding incident at her spinal cord seen on MRI, likely Von Willebrand's Disease related http://bit.ly/hU9G05
Wilate available for bleeding episodes in von Willebrand disease (VWD) - MPR
empr.com — “Octapharma announced that wilate (double virus inactivated von Willebrand Factor/Coagulation Factor VIII concentrate [human]) is now available by prescription for the treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as in patients with mild or moderate forms of the illness in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.” View full resource at empr.com
Most Recently Shared on May 13, 2010 at 5:11 pm By:
MPR News: Wilate available for bleeding episodes in von Willebrand disease (VWD): Octapharma announced that wilate... http://bit.ly/dDrjg9
Wilate approved for bleeding episodes in von Willebrand disease (VWD) - MPR
empr.com — “The FDA has approved wilate (double virus inactivated von Willebrand Factor/Coagulation Factor VIII concentrate [human], from Octapharma USA) for the treatment of spontaneous and trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.” View full resource at empr.com
Most Recently Shared on December 8, 2009 at 5:00 pm By:
MPR News: Wilate approved for bleeding episodes in von Willebrand disease (VWD): The FDA has approved wilate (doubl... http://bit.ly/7wpaRp
Wilate available for bleeding episodes in von Willebrand disease (VWD) - MPR
empr.com — “Octapharma announced that wilate (double virus inactivated von Willebrand Factor/Coagulation Factor VIII concentrate [human]) is now available by prescription for the treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as in patients with mild or moderate forms of the illness in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.” View full resource at empr.com
Most Recently Shared on May 13, 2010 at 7:45 pm By:
Wilate available for bleeding episodes in von Willebrand disease (VWD): Octapharma announced that wilate (double v... http://bit.ly/9Cmq6c
Hemophilia and Von Willebrand disease - In-Depth - Children's Hospital Boston
childrenshospital.org — “Hemophilia is a blood clotting problem in which a simple cut can cause uncontrollable bleeding because the body lacks blood clotting proteins. Each year, about 400 children with hemophilia are born. At Children's Hospital Boston, the Boston Hemophilia Center will provide hemophilia support through a comprehensive care model.” View full resource at childrenshospital.org
Most Recently Shared on March 16, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
Besides prolonged bleeding, do you know the other symptoms of hemophilia? http://t.co/DuIhhevk
Hemophilia and Von Willebrand disease - Research & Innovation - Children's Hospital Boston
childrenshospital.org — “Hemophilia is a blood clotting problem in which a simple cut can cause uncontrollable bleeding because the body lacks blood clotting proteins. Each year, about 400 children with hemophilia are born. At Children's Hospital Boston, the Boston Hemophilia Center will provide hemophilia support through a comprehensive care model.” View full resource at childrenshospital.org
Most Recently Shared on March 15, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
Read about our clinical research trials available for children with hemophilia: http://t.co/D9tCinyd
Hemophilia and Von Willebrand disease - Treatment & Care - Children's Hospital Boston
childrenshospital.org — “Hemophilia is a blood clotting problem in which a simple cut can cause uncontrollable bleeding because the body lacks blood clotting proteins. Each year, about 400 children with hemophilia are born. At Children's Hospital Boston, the Boston Hemophilia Center will provide hemophilia support through a comprehensive care model.” View full resource at childrenshospital.org
Most Recently Shared on March 13, 2012 at 7:30 pm By:
Children's Hospital Hospital and Children's Hospital
If your child has hemophilia, here are some ways you can help protect their health: http://t.co/kEHC5GR8
Octapharma USA Announces FDA Approval of Wilate - the First Replacement Therapy Developed Specifically for von Willebrand Disease
drugs.com — “Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)) is used to treat von Willebrand disease (VWD). Includes Wilate side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 9, 2009 at 11:29 pm By:
FDA Approves Wilate - First Replacement Therapy Developed Specifically for von Willebrand Disease - http://bit.ly/5kvip0
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product
rttnews.com — “Baxter International Inc. (BAX) Thursday reported initiating the Phase III trial of its investigational recombinant von Willebrand factor, or rWWF, BAX 111 as preventive therapy for patients with von Willebrand disease, an inherited bleeding disorder.” View full resource at rttnews.com
Most Recently Shared on October 17, 2011 at 2:28 am By:
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product
rttnews.com — “Baxter International Inc. (BAX) Thursday reported initiating the Phase III trial of its investigational recombinant von Willebrand factor, or rWWF, BAX 111 as preventive therapy for patients with von Willebrand disease, an inherited bleeding disorder.” View full resource at rttnews.com
Most Recently Shared on October 17, 2011 at 2:28 am By:
Susan Scroggins - vWD Arkansas Patient Advocate and Active Health Library
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product http://t.co/TA5NFFWP via @rttnews
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
KidsHealth
KidsHealth is the most-trusted website for health and development information written for parents, kids and teens.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
VeoMed Team
VeoMed is an Open Access Medical Education Resource.
Advertisement
